menu search

Live: indian equities gear up for a cautious start | hdfc bank’s top mgmt in focus | opening bell

Domestic benchmark indices are likely to get a cautious start as RBI policy committee members start monetary policy decisions. Stocks to watch out for...

October 4, 2023, 3:59 am

Ares management corporation to present at the bofa securities 28th annual financials ceo conference

NEW YORK, NY / ACCESSWIRE / September 18, 2023 / Ares Management Corporation announced today that its Chief Executive Officer and President, Michael A...

September 18, 2023, 6:00 am

Ncla asks supreme court to hear securities law appeal with major first amendment implications

Rev. Father Emmanuel Lemelson and Lemelson Capital mgmt., LLC v. Securities and Exchange Commission Was...

August 1, 2023, 11:12 pm

Sarepta therapeutics: value proposition ahead of dmd gene therapy decision

Sarepta Therapeutics should earn ~$1bn from its Duchenne Muscular Dystrophy franchise in 2023 - although the company has made eye-watering losses in r...

June 22, 2023, 8:45 am

Ares management corporation to present at the bernstein 39th annual strategic decisions conference

NEW YORK--(BUSINESS WIRE)--Ares Management Corporation announced today that its Chief Executive Officer and President, Michael Arougheti, is scheduled...

May 22, 2023, 6:30 am

Microsoft, google report earnings beats - deepwater's gene munster delivers analysis

Gene Munster, Deepwater Asset mgmt. Managing Partner, reacts to Alphabet and Microsoft earnings with CN...

April 25, 2023, 6:22 pm

Innes: oil could hit $100 as market nears feb. 1

SPI Asset mgmt Managing Partner Stephen Innes thinks oil could hit $100, as the market nears Feb. 1. He...

January 5, 2023, 3:41 pm

Candel therapeutics announces late-breaking oral presentation at sitc annual meeting with data on can-2409 in combination with nivolumab in a phase 1 mechanistic clinical trial in patients with high-g

Combination of nivolumab and CAN-2409 delivered during neurosurgery was generally well tolerated with no significant added toxicity compared to standa...

November 11, 2022, 5:00 pm

Candel therapeutics announces late-breaking oral presentation at sitc annual meeting with data on can-2409 in combination with nivolumab in a phase 1 mechanistic clinical trial in patients with high-g

Combination of nivolumab and CAN-2409 delivered during neurosurgery was generally well tolerated with no significant added toxicity compared to standa...

November 11, 2022, 5:00 pm

Candel therapeutics announces late-breaking oral presentation at sitc annual meeting with data on can-2409 in combination with nivolumab in a phase 1 mechanistic clinical trial in patients with high-g

Combination of nivolumab and CAN-2409 delivered during neurosurgery was generally well tolerated with no significant added toxicity compared to standa...

November 11, 2022, 5:00 pm

Candel therapeutics announces late-breaking oral presentation at sitc annual meeting with data on can-2409 in combination with nivolumab in a phase 1 mechanistic clinical trial in patients with high-g

Combination of nivolumab and CAN-2409 delivered during neurosurgery was generally well tolerated with no significant added toxicity compared to standa...

November 11, 2022, 5:00 pm

Morgan stanley downgrades seagate, cuts price target by 25%

Morgan Stanley analyst Katy Huberty downgraded Seagate Technology Holdings PLC (NASDAQ:STX) from Overweight to Equal-weight with a price target o...

October 6, 2021, 6:48 am

Morgan stanley downgrades seagate, cuts price target by 25%

Morgan Stanley analyst Katy Huberty downgraded Seagate Technology Holdings PLC (NASDAQ:STX) from Overweight to Equal-weight with a price target o...

October 6, 2021, 6:48 am

Morgan stanley downgrades seagate, cuts price target by 25%

Morgan Stanley analyst Katy Huberty downgraded Seagate Technology Holdings PLC (NASDAQ:STX) from Overweight to Equal-weight with a price target o...

October 6, 2021, 6:48 am


Search within

Pages Search Results: